- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 295/02 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
Patent holdings for IPC class C07D 295/02
Total number of patents in this class: 107
10-year publication summary
|
3
|
2
|
3
|
2
|
3
|
4
|
4
|
4
|
1
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| BASF SE | 21098 |
18 |
| Glaxosmithkline LLC | 535 |
3 |
| Hokko Chemical Industry Co., Ltd. | 50 |
3 |
| F. Hoffmann-La Roche AG | 7937 |
2 |
| Cellixbio Private Limited | 152 |
2 |
| Eli Lilly and Company | 3926 |
2 |
| Incyte Corporation | 1039 |
2 |
| H. Lundbeck A/S | 1237 |
2 |
| Nectar Health Sciences Inc. | 11 |
2 |
| Glaxo Group Limited | 4145 |
1 |
| Hoffmann-La Roche Inc. | 3546 |
1 |
| Boehringer Ingelheim International GmbH | 4636 |
1 |
| Boehringer Ingelheim Pharma GmbH & Co. Kg | 498 |
1 |
| Centre National de La Recherche Scientifique | 10706 |
1 |
| Bayer Pharma AG | 1048 |
1 |
| FUJIFILM Corporation | 29839 |
1 |
| Nitto Denko Corporation | 8358 |
1 |
| Board of Regents, The University of Texas System | 5946 |
1 |
| Commissariat à l'énergie atomique et aux energies alternatives | 10954 |
1 |
| Idemitsu Kosan Co., Ltd. | 4223 |
1 |
| Other owners | 60 |